» Articles » PMID: 24028699

Shifting the Paradigm: Using HIV Surveillance Data As a Foundation for Improving HIV Care and Preventing HIV Infection

Overview
Journal Milbank Q
Date 2013 Sep 14
PMID 24028699
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Reducing HIV incidence in the United States and improving health outcomes for people living with HIV hinge on improving access to highly effective treatment and overcoming barriers to continuous treatment. Using laboratory tests routinely reported for HIV surveillance to monitor individuals' receipt of HIV care and contacting them to facilitate optimal care could help achieve these objectives. Historically, surveillance-based public health intervention with individuals for HIV control has been controversial because of concerns that risks to privacy and autonomy could outweigh benefits. But with the availability of lifesaving, transmission-interrupting treatment for HIV infection, some health departments have begun surveillance-based outreach to facilitate HIV medical care.

Methods: Guided by ethics frameworks, we explored the ethical arguments for changing the uses of HIV surveillance data. To identify ethical, procedural, and strategic considerations, we reviewed the activities of health departments that are using HIV surveillance data to contact persons identified as needing assistance with initiating or returning to care.

Findings: Although privacy concerns surrounding the uses of HIV surveillance data still exist, there are ethical concerns associated with not using HIV surveillance to maximize the benefits from HIV medical care and treatment. Early efforts to use surveillance data to facilitate optimal HIV medical care illustrate how the ethical burdens may vary depending on the local context and the specifics of implementation. Health departments laid the foundation for these activities by engaging stakeholders to gain their trust in sharing sensitive information; establishing or strengthening legal, policy and governance infrastructure; and developing communication and follow-up protocols that protect privacy.

Conclusions: We describe a shift toward using HIV surveillance to facilitate optimal HIV care. Health departments should review the considerations outlined before implementing new uses of HIV surveillance data, and they should commit to an ongoing review of activities with the objective of balancing beneficence, respect for persons, and justice.

Citing Articles

HIV epidemic among key populations in Nigeria: results of the integrated biological and behavioural surveillance survey (IBBSS), 2020-2021.

Emmanuel F, Ejeckam C, Green K, Adesina A, Aliyu G, Ashefor G Sex Transm Infect. 2024; 101(1):10-16.

PMID: 39379313 PMC: 11877050. DOI: 10.1136/sextrans-2023-056067.


Predictors of HIV Care Outcomes among Recently Out-of-Care Individuals in The Massachusetts Cooperative Re-engagement Controlled Trial Cohort.

Pokhrel D, Lang S, Elder H, John B, Roosevelt K, Klevens M AIDS Behav. 2024; 28(11):3883-3892.

PMID: 39172186 DOI: 10.1007/s10461-024-04457-1.


The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People 'Lost to Follow Up'.

Saich F, Walker S, Hellard M, Stoove M, Seear K Public Health Ethics. 2024; 17(1-2):40-52.

PMID: 39005529 PMC: 11245707. DOI: 10.1093/phe/phae006.


Exploring salivary metabolome alterations in people with HIV: towards early diagnostic markers.

Du F, Li R, He R, Li K, Liu J, Xiang Y Front Public Health. 2024; 12:1400332.

PMID: 38912274 PMC: 11192068. DOI: 10.3389/fpubh.2024.1400332.


Using Data-To-Care Strategies to Optimize the HIV Care Continuum in Connecticut: Results From a Randomized Controlled Trial.

Machavariani E, Miceli J, Altice F, Fanfair R, Speers S, Nichols L J Acquir Immune Defic Syndr. 2024; 96(1):40-50.

PMID: 38324241 PMC: 11009056. DOI: 10.1097/QAI.0000000000003391.


References
1.
Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

2.
Childress J, Faden R, Gaare R, Gostin L, Kahn J, Bonnie R . Public health ethics: mapping the terrain. J Law Med Ethics. 2002; 30(2):170-8. DOI: 10.1111/j.1748-720x.2002.tb00384.x. View

3.
Nieuwkerk P, Oort F . Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005; 38(4):445-8. DOI: 10.1097/01.qai.0000147522.34369.12. View

4.
Horberg M, Hurley L, Towner W, Gambatese R, Klein D, Antoniskis D . HIV quality performance measures in a large integrated health care system. AIDS Patient Care STDS. 2011; 25(1):21-8. DOI: 10.1089/apc.2010.0315. View

5.
Sperling R, Shapiro D, Coombs R, Todd J, Herman S, McSherry G . Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996; 335(22):1621-9. DOI: 10.1056/NEJM199611283352201. View